J Hepatol:母亲肥胖会增加后代患肝癌的概率,且可以世代累积!

2020-07-26 佚名 细胞

科学家认识到母亲的肥胖和肥胖母亲的后代患肝癌之间的联系,但其机制尚不清楚。研究人员在肥胖的母鼠体内发现了一种microRNA,它似乎可以传递肝癌易感性,增加子代和后代患肝癌的几率。

科学家认识到母亲的肥胖和肥胖母亲的后代患肝癌之间的联系,但其机制尚不清楚。在一项发表在Journal of Hepatology杂志上的新研究中,研究人员在肥胖的母鼠体内发现了一种microRNA,它似乎可以传递肝癌易感性,增加子代和后代患肝癌的几率。

世界人口的三分之一超重或肥胖,这种全球肥胖流行病正威胁着人类健康。肥胖会增加患代谢性疾病的风险,如非酒精性脂肪肝病(NAFLD)和肝细胞癌(HCC)。在美国,最近诊断出的HCC中,有高达50%是由NAFLD等肝脏代谢紊乱引起的。

母亲肥胖直接影响到后代的健康,在肥胖症和代谢疾病中扮演着关键角色。流行病学研究表明,肥胖是肝癌的独立危险因素。这项新研究为母亲的肥胖是否以及如何影响后代的肿瘤发病率提供了见解。

研究人员用二乙基亚硝胺(DEN)诱导食用高脂肪食物的肥胖小鼠患上肝癌,随后进行了RNA测序,以确定基因和microRNAs的世代变化。他们发现,向怀孕小鼠注射microRNA miR-27a-3p不仅增加了肝脏的miR-27a-3p,降低了子代(胎儿期、幼龄期和成体期)中Acsl1和Aldh2两个基因的表达,而且还加剧了接受过DEN处理的子代HCC的发展。

高脂肪饮食引起的母亲肥胖会导致后代易患DEN诱发的HCC,研究人员证实这种易感性是世代累积的。此外,发生肝癌的几率在两代之间增加。例如,肥胖母亲和祖母所生孩子的严重程度要高于肥胖母亲但祖母体重正常的孩子。

研究人员还分析了人类HCC样本。研究人员表示,他们的发现提供了母体肥胖与后代疾病发展之间的机制联系,这将有助于探索对胎儿和发育性疾病的治疗和预防。对于孕妇来说,血清miR-27a-3p水平对后代的健康至关重要,未来可能被用作诊断或预测的生物标志物。因此,研究人员呼吁全球共同努力解决人类多代肥胖问题,以更好地解决我们面临的这个共同问题。

这项研究在新陈代谢和表观遗传学的十字路口为癌症研究开辟了一条新途径。它带来了关于母亲压力如何影响其后代,进而影响HCC发展的新信息。继承的模式并不是传统的代际传承模式。这是多代的,因为对HCC的易感性在几代之后逐渐增加。

原始出处:

Yu Sun 1, Qing Wang 1, Yu Zhang 2, et al.Multi-generational maternal obesity increases the incidence of HCC in offspring via miR-27a-3p.J Hepatol. 2020 Apr 15;S0168-8278(20)30216-6. doi: 10.1016/j.jhep.2020.03.050.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1427440, encodeId=6c06142e44019, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Tue Jul 28 06:01:27 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804645, encodeId=442f80464532, content=肥胖是个问题!, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200726/1b2bf7a3c7874be6828cfafac5982486/469fc73f0ffc4157beba39e5d791762f.jpg, createdBy=38231815492, createdName=ms4324888274376176, createdTime=Sun Jul 26 20:48:40 CST 2020, time=2020-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804629, encodeId=1eb28046292c, content=有些不靠谱, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Jul 26 18:29:59 CST 2020, time=2020-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1040306, encodeId=9a1d104030632, content=肝癌,接下来就要细分了,对于体质好的病人,能否将PD-1类+抗血管新生+放疗等相结合,甚至有必要用TACE进行减负, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=留走人康, createdTime=Sun Jul 26 18:01:27 CST 2020, time=2020-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804622, encodeId=ff128046227c, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Sun Jul 26 17:46:25 CST 2020, time=2020-07-26, status=1, ipAttribution=)]
    2020-07-28 gwc384
  2. [GetPortalCommentsPageByObjectIdResponse(id=1427440, encodeId=6c06142e44019, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Tue Jul 28 06:01:27 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804645, encodeId=442f80464532, content=肥胖是个问题!, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200726/1b2bf7a3c7874be6828cfafac5982486/469fc73f0ffc4157beba39e5d791762f.jpg, createdBy=38231815492, createdName=ms4324888274376176, createdTime=Sun Jul 26 20:48:40 CST 2020, time=2020-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804629, encodeId=1eb28046292c, content=有些不靠谱, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Jul 26 18:29:59 CST 2020, time=2020-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1040306, encodeId=9a1d104030632, content=肝癌,接下来就要细分了,对于体质好的病人,能否将PD-1类+抗血管新生+放疗等相结合,甚至有必要用TACE进行减负, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=留走人康, createdTime=Sun Jul 26 18:01:27 CST 2020, time=2020-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804622, encodeId=ff128046227c, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Sun Jul 26 17:46:25 CST 2020, time=2020-07-26, status=1, ipAttribution=)]
    2020-07-26 ms4324888274376176

    肥胖是个问题!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1427440, encodeId=6c06142e44019, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Tue Jul 28 06:01:27 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804645, encodeId=442f80464532, content=肥胖是个问题!, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200726/1b2bf7a3c7874be6828cfafac5982486/469fc73f0ffc4157beba39e5d791762f.jpg, createdBy=38231815492, createdName=ms4324888274376176, createdTime=Sun Jul 26 20:48:40 CST 2020, time=2020-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804629, encodeId=1eb28046292c, content=有些不靠谱, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Jul 26 18:29:59 CST 2020, time=2020-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1040306, encodeId=9a1d104030632, content=肝癌,接下来就要细分了,对于体质好的病人,能否将PD-1类+抗血管新生+放疗等相结合,甚至有必要用TACE进行减负, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=留走人康, createdTime=Sun Jul 26 18:01:27 CST 2020, time=2020-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804622, encodeId=ff128046227c, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Sun Jul 26 17:46:25 CST 2020, time=2020-07-26, status=1, ipAttribution=)]
    2020-07-26 lovetcm

    有些不靠谱

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1427440, encodeId=6c06142e44019, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Tue Jul 28 06:01:27 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804645, encodeId=442f80464532, content=肥胖是个问题!, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200726/1b2bf7a3c7874be6828cfafac5982486/469fc73f0ffc4157beba39e5d791762f.jpg, createdBy=38231815492, createdName=ms4324888274376176, createdTime=Sun Jul 26 20:48:40 CST 2020, time=2020-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804629, encodeId=1eb28046292c, content=有些不靠谱, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Jul 26 18:29:59 CST 2020, time=2020-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1040306, encodeId=9a1d104030632, content=肝癌,接下来就要细分了,对于体质好的病人,能否将PD-1类+抗血管新生+放疗等相结合,甚至有必要用TACE进行减负, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=留走人康, createdTime=Sun Jul 26 18:01:27 CST 2020, time=2020-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804622, encodeId=ff128046227c, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Sun Jul 26 17:46:25 CST 2020, time=2020-07-26, status=1, ipAttribution=)]
    2020-07-26 留走人康

    肝癌,接下来就要细分了,对于体质好的病人,能否将PD-1类+抗血管新生+放疗等相结合,甚至有必要用TACE进行减负

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1427440, encodeId=6c06142e44019, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6851, encryptionId=221d685172, topicName=EPA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9b4077760, createdName=gwc384, createdTime=Tue Jul 28 06:01:27 CST 2020, time=2020-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804645, encodeId=442f80464532, content=肥胖是个问题!, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200726/1b2bf7a3c7874be6828cfafac5982486/469fc73f0ffc4157beba39e5d791762f.jpg, createdBy=38231815492, createdName=ms4324888274376176, createdTime=Sun Jul 26 20:48:40 CST 2020, time=2020-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804629, encodeId=1eb28046292c, content=有些不靠谱, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Sun Jul 26 18:29:59 CST 2020, time=2020-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1040306, encodeId=9a1d104030632, content=肝癌,接下来就要细分了,对于体质好的病人,能否将PD-1类+抗血管新生+放疗等相结合,甚至有必要用TACE进行减负, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=留走人康, createdTime=Sun Jul 26 18:01:27 CST 2020, time=2020-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804622, encodeId=ff128046227c, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Sun Jul 26 17:46:25 CST 2020, time=2020-07-26, status=1, ipAttribution=)]
    2020-07-26 wxl882001

    了解一下

    0

相关资讯

Lancet Diabetes and Endocrinology:这些物质正在摧毁健康,引发肥胖、不孕不育、癌症等问题

狄更斯在世界名着《双城记》的开头写道,“这是最好的时代,这是最坏的时代。”在科学技术飞速发展的今天,人们的生活越来越便利,但是生活环境却越来越糟,各种疾病和灾难更加频繁地出现。

JCO:肥胖又耽误事儿!大型回顾性分析表明,肥胖乳腺癌患者化疗效果差!

治疗期间,肥胖也是个捣蛋鬼,就见不得患者好。现有研究表明,乳腺癌患者肥胖或超重,化疗效果会大大减少。

Nat Rev Endocrinol:糖尿病及肥胖症治疗的新方法:点燃产热的脂肪组织

产热脂肪组织能消耗生物体内过量的能量,也有希望成为治疗肥胖症和2型糖尿病的新靶点。近日《Nat Rev Endocrinol》上的一篇论文阐述了一种激活脂肪组织产热代谢的新方法。

Nat Metab:母亲运动通过改变母乳成分,促进后代代谢健康

研究人员确定了运动可以诱导人和小鼠母乳中低聚糖3′-唾液乳糖(3′-SL)的增加,并表明母体运动对小鼠后代代谢健康和心脏功能的有益影响是由3′-SL介导的。

GUT:地中海饮食降低超重和肥胖受试者的血浆胆固醇并改善肠道微生物组成

“地中海式饮食”是指有利于健康的,简单、清淡以及富含营养的饮食。本研究旨在探讨地中海饮食(MD)干预对具有代谢性疾病危险因素的受试者代谢,肠道微生物组和系统代谢组的影响。

JAHA:青少年肥胖对成年心血管代谢风险的影响

年轻时期超重或者肥胖对未来健康的长期影响尚不清楚。本研究目的是评估从青年时期超重或肥胖的持续时间是否与成人心脏代谢风险相关。